A detailed history of Round Rock Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Round Rock Advisors, LLC holds 19,978 shares of ABBV stock, worth $3.33 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
19,978
Previous 23,558 15.2%
Holding current value
$3.33 Million
Previous $3.65 Million 0.36%
% of portfolio
0.88%
Previous 0.92%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $3.19 Million - $3.64 Million
19,978 New
19,978 $3.64 Million
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $3.24 Million - $3.65 Million
23,558 New
23,558 $3.65 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Round Rock Advisors, LLC Portfolio

Follow Round Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Rock Advisors, LLC with notifications on news.